MedPath

Intraoperative Methadone for Postoperative Pain Control

Phase 4
Withdrawn
Conditions
Bariatric Surgery Candidate
Interventions
Registration Number
NCT05845359
Lead Sponsor
Montefiore Medical Center
Brief Summary

To compare patient pain perception and satisfaction as well as opioid-related side effects during inpatient and outpatient care when undergoing bariatric enhanced recovery after surgery protocols with and without methadone.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

• All patients undergoing initial gastric sleeve resection

Exclusion Criteria
  • Age <18 years or >60 years
  • Patients with BMI >60
  • AHI > 30 (AHI = Apnea-Hypopnea Index), indicative of severe Obstructive Sleep Apnea (OSA)
  • ASA IV or V (American Society of Anesthesiology physical status classification system)
  • Patients taking opioids for chronic conditions in the last 10 days preceding the surgery
  • Patients currently being treated for chronic opioid addiction
  • Patients with severe psychiatric diagnoses
  • Allergies to medications used in protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Methadone groupMethadonePatients in this group will receive intraoperative methadone.
Primary Outcome Measures
NameTimeMethod
Postoperative opioid use24 hours postoperatively

Postoperative opioid use will be determined by the amount of morphine consumed (milligram morphine equivalents, MME) at 24 hours postoperatively

Secondary Outcome Measures
NameTimeMethod
Total Postoperative opioid use48 hours postoperatively and approximately at 2 weeks (follow up visit upon discharge)

Total postoperative opioid use will be determined by the total amount of morphine consumed (milligram morphine equivalents, MME) at 48 hours postoperatively and during follow up visit

Opioid-related side effectsUp to 2 days postoperatively

Opioid related side effects including nausea, vomiting, pruritis, urinary retention, and necessity of supplemental oxygen will be recorded

Pain ScoresAfter 30 minutes in the PACU; upon discharge from PACU (variable timepoint); at 6, 12, 18, and 24 hours after being on the in-patient floor; and at hospital discharge

Pain scores will be assessed by a research assistant blinded to the study group at regular intervals. Numerical pain scores (0=no pain, 10=most pain) will be assigned on an 11 point scale ranging from 0 (no pain) to 10 (most pain). Since most patients who get bariatric surgery are discharged at POD 1, the research assistant will call the patient the morning of POD 2 to assess the pain score if not on the inpatient floor. If the patients are not yet discharged, the pain score will be assessed the morning of POD 2, otherwise pain scores will be collected as detailed in the time frame below.

Duration of hospital stayApproximately 5 days postoperatively

The average duration of hospitalization will be determined per patient

Sedation Score (POSS)2 days postoperatively

Sedation score will be determined using the Pasero Opioid-induced Sedation Scale (POSS) in the Post-anesthesia Care Unit (PACU) and on the floor. Average scores will be tabulated per patient using a four point numeric rating scale. Scoring is as follows: 1 = Awake and alert; 2 = Slightly drowsy, easily aroused; 3 = Frequently drowsy, arousable, drifts off to sleep during conversation; 4 = Somnolent, minimal or no response to verbal and physical stimulation

Agitation and Sedation Severity (RASS)2 days postoperatively

Agitation and Sedation severity will determined using the Richmond Agitation-Sedation Scale (RASS) in the PACU and on the floor. Average scores will be determined per patient using a numeric rating scale ranging from +4 to -5 where +4 = combative, +3 = very agitated, +2 = agitated, +1 = restless, 0 = alert and calm, -1: = drowsy, -2 = light sedation, -3 = moderate sedation, -4 = deep sedation, and -5 = unarousable. Ideal RASS scores range from -1 to 1.

Early MobilizationUp to 2 days postoperatively

The average duration of time to first ambulation after surgery will be recorded per patient

Adverse events due to procedure or anesthesiaUp to 2 days postoperatively

Procedure related adverse events or adverse events related to anesthesia will be recorded

Respiratory interventionsUp to 4 hours postoperatively

The number of respiratory interventions required postoperatively per patient in the PACU (Post-anesthesia care unit) will be determined

Patients Perception of Pain Management2 days postoperatively

Patients perceptions of pain management will be measured by administration of the International Pain Outcomes (IPO) questionnaire on POD 1 (Post-Operative Day 1). IPO will be used to assess key patient level outcomes of postoperative pain management and consists of 13 questions evaluating four outcome domains: 1) intensity of pain rated on numeric rating score (0 = no pain, 10 = worst possible pain); 2) interference of pain with activities and emotional well-being as determined by a score analogous to the 0-10 scale above; 3) side effects of pain treatment, including nausea, drowsiness, itching, and dizziness, as determined by the NRS score \>0; and 4) perception of care, treatment satisfaction and involvement in pain treatment decision-making on a scale from 0-10. Scores are aggregated per patient with higher overall scores indicative of a worsening perception of pain management.

GI recovery timeUp to 2 days postoperatively

The average duration of time to return of bowel function will be determined per patient

© Copyright 2025. All Rights Reserved by MedPath